Prof. Manzhao Ouyang

The First People’s Hospital of Shunde Foshan, China

Professor

Email: [email protected]

Qualifications

2019 Ph.D., Southern Medical University, China

Publications (Selected)

1. Cheng, F.Y., Huang, L., Peng, Y. and Ouyang, M. Regulatory Role of Phosphatidylcholine Metabolic Reprogramming in Colorectal Cancer Progression and Neutrophil Interactions. iScience, 2025.
2. Zhong, L., Peng, Y., Luo, L. and Ouyang, M. Associations of serum lead with colorectal cancer: data from NHANES 1999-2020. Journal of Cancer, 2025.
3. Peng, G., Zhong, L., Lai, N. and Ouyang, M. Identification of copper metabolism-related subtypes, the development of a prognosis model, and characterization of the immune landscape in colorectal cancer. Discover Oncology, 2025.
4. Peng, G., Zhong, L., Luo, L. and Ouyang, M. Cancer cell SPOCD1 promotes colorectal cancer liver metastasis by activating the CXCL12/CXCR4 signaling pathway in cancer-associated fibroblasts. Journal of Translational Medicine, 2025.
5. Lu, Y., Wang, K., Peng, Y. and He, Z. Hsa-miR-214-3p inhibits breast cancer cell growth and improves the tumor immune microenvironment by downregulating B7H3. Oncology Research, 2024.
6. Yang, R., Lai, C., Huang, L. and Lin, Y. Role of disulfidptosis in colorectal adenocarcinoma: implications for prognosis and immunity. Frontiers in Immunology, 2024.
7. Wang, K., Yu, J., Xu, Q. and Ouyang, M. Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma. Apoptosis, 2024.
8. Wang, K., Lu, Y., Li, H. and Ouyang, M. Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells. Cancer Cell International, 2024.
9. Wang, K., Yu, J., Xu, Q. and Ouyang, M. Disulfidptosis-related Long Non-Coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma. Preprint, 2024.
10. Yu, J., Peng, Y., Wang, K. and Ouyang, M. The combination of elesclomol and Cu2+ can inhibit the growth of colon cancer cells by targeting FDX1. Preprint, 2023.
11. Huang, L., Li, W., Lu, Y. and Ouyang, M. Iron metabolism in colorectal cancer. Frontiers in Oncology, 2023.
12. Cheng, F.Y., Peng, G., Lu, Y. and Ouyang, M. Relationship between copper and immunity: The potential role of copper in tumor immunity. Frontiers in Oncology, 2022.
13. Liao, T., Lu, Y., Li, W. and Ouyang, M. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma. Frontiers in Genetics, 2022.
14. Lu, Y., Deng, M., Wang, K. and Ouyang, M. The Regulatory Effects of MicroRNAs on Tumor Immunity. BioMed Research International, 2022.
15. Wang, K., Zhang, J., Deng, M. and Ouyang, M. METTL27 is a prognostic biomarker of colon cancer and associated with immune invasion. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2022.
16. Li, Z., Lu, Y., Wang, K. and Ouyang, M. Comparison of Intestinal Stent Placement Followed By Laparoscopic Surgery and Emergency Surgery in Obstructive Colorectal Cancer: A Retrospective Analysis and Meta-analysis. Preprint, 2021.
17. Li, W., Lu, Y., Ye, C. and Ouyang, M. The Regulatory Network of MicroRNA in the Metabolism of Colorectal Cancer. Journal of Cancer, 2021.

Personal Details

WoS Researcher ID: U-2758-2017

https://orcid.org/0009-0004-6308-5248